Picture of Travere Therapeutics logo

TVTX — Travere Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Travere Therapeutics Q1 EPS USD -0.47 Vs. IBES Estimate USD -0.54

May 01 (Reuters) - Travere Therapeutics Q1 product sales USD 75.861 million vs. IBES estimate USD 77.6 million.

Q1 operating expenses USD 124.406 million

Q1 operating income USD -42.674 million vs. IBES estimate USD -47.2 million

Q1 net income USD -41.226 million

Recent news on Travere Therapeutics

See all news